Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Melanoma and related-topic references (MedlinePlus Genetics), a Locations section including Virginia, and a footer revision to v3.3.3, while removing HHS Vulnerability Disclosure and Virginia Locations with an update to v3.3.2.SummaryDifference0.4%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRemoved the topic 'Melanoma' and the related topic 'MedlinePlus Genetics' from the study page's taxonomy/related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics). Updated the page revision from v3.3.1 to v3.3.2.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision: v3.3.1 was added; Melanoma and the related topic MedlinePlus Genetics, as well as Revision: v3.2.0, were removed.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) to the page's topics; removed the government funding status notice.SummaryDifference0.6%

- Check60 days agoChange DetectedRemoved Melanoma and related topics MedlinePlus Genetics from the page.SummaryDifference0.2%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.